Advertisement

French regional surveillance program of carbapenemase-producing Gram-negative bacilli: results from a 2-year period

  • A. Pantel
  • A. Boutet-Dubois
  • H. Jean-Pierre
  • H. Marchandin
  • A. Sotto
  • J.-P. Lavigne
  • on behalf of the CARB-LR group
Article

Abstract

In February 2011, the CARB-LR group was created as a sentinel laboratory-based surveillance network to control the emergence of carbapenem-resistant Gram-negative bacilli (CR GNB) in a French Southern Region. We report the epidemiological results of a 2-year study. All the Gram-negative bacilli isolates detected in the different labs (hospital and community settings) of a French Southern Region and with reduced susceptibility to ertapenem and/or imipenem were characterised with regard to antibiotic resistance, bla genes content, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multilocus sequence typing (MLST). A total of 221 strains were analysed. Acinetobacter baumannii was the most prevalent carbapenemase-producing bacteria, with a majority of OXA-23 producers (n = 37). One isolate co-produced OXA-23 and OXA-58 enzymes. Klebsiella pneumoniae was the most frequent carbapenemase-producing Enterobacteriaceae (CPE) (OXA-48 producer: n = 29, KPC producer: n = 1), followed by Escherichia coli (OXA-48 producer: n = 8, KPC producer: n = 1) and Enterobacter cloacae (OXA-48 producer, n = 1). One isolate of Pseudomonas aeruginosa produced a VIM-1 carbapenemase. A clonal diversity of carbapenemase-producing K. pneumoniae and E. coli was noted with different MLSTs. On the other hand, almost all OXA-23-producing A. baumannii strains belonged to the widespread ST2/international clone II. The link between the detection of CR GNB and a foreign country was less obvious, suggesting the beginning of a local cross-transmission. The number of CR GNB cases in our French Southern Region has sharply increased very recently due to the diffusion of OXA-48 producers.

Keywords

AmpC Ertapenem Doripenem Plasmidic AmpC 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

INSERM U1047 is supported by INSERM and Université de Montpellier 1.

Conflict of interest

The authors report no conflicting interests.

References

  1. 1.
    Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen Ø, Seifert H, Woodford N, Nordmann P; European Network on Carbapenemases (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413–431CrossRefPubMedGoogle Scholar
  2. 2.
    Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y (2008) Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:1028–1033CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    European Centre for Disease Prevention and Control (ECDC) (2012) Antimicrobial resistancesurveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm. Available online at: http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf Google Scholar
  4. 4.
    Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P (2011) Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol 49:1608–1613CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153–2162CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351–353CrossRefPubMedGoogle Scholar
  7. 7.
    Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119–123CrossRefPubMedGoogle Scholar
  8. 8.
    Chia JH, Su LH, Lee MH, Kuo AJ, Shih NY, Siu LK, Wu TL (2010) Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure. Microb Drug Resist 16:317–325CrossRefPubMedGoogle Scholar
  9. 9.
    Potron A, Poirel L, Rondinaud E, Nordmann P (2013) Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill 18. pii: 20549Google Scholar
  10. 10.
    Vaux S, Carbonne A, Thiolet JM, Jarlier V, Coignard B; RAISIN and Expert Laboratories Groups (2011) Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Euro Surveill 16. pii: 19880Google Scholar
  11. 11.
    Pitart C, Solé M, Roca I, Fàbrega A, Vila J, Marco F (2011) First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 55:4398–4401CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Österblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J (2012) Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008–11). J Antimicrob Chemother 67:2860–2864CrossRefPubMedGoogle Scholar
  13. 13.
    Dimou V, Dhanji H, Pike R, Livermore DM, Woodford N (2012) Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J Antimicrob Chemother 67:1660–1665CrossRefPubMedGoogle Scholar
  14. 14.
    Damjanova I, Tóth A, Pászti J, Hajbel-Vékony G, Jakab M, Berta J, Milch H, Füzi M (2008) Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005—the new ‘MRSAs’? J Antimicrob Chemother 62:978–985CrossRefPubMedGoogle Scholar
  15. 15.
    Sánchez-Romero I, Asensio A, Oteo J, Muñoz-Algarra M, Isidoro B, Vindel A, Alvarez-Avello J, Balandín-Moreno B, Cuevas O, Fernández-Romero S, Azañedo L, Sáez D, Campos J (2012) Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 56:420–427CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Potron A, Kalpoe J, Poirel L, Nordmann P (2011) European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect 17:E24–E26CrossRefPubMedGoogle Scholar
  17. 17.
    Balm MN, Ngan G, Jureen R, Lin RT, Teo JW (2013) OXA-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect Dis 13:58CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Poirel L, Bernabeu S, Fortineau N, Podglajen I, Lawrence C, Nordmann P (2011) Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob Agents Chemother 55:4937–4938CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Benouda A, Touzani O, Khairallah MT, Araj GF, Matar GM (2010) First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco. Ann Trop Med Parasitol 104:327–330CrossRefPubMedGoogle Scholar
  20. 20.
    Hays C, Benouda A, Poirel L, Elouennass M, Nordmann P (2012) Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital. Int J Antimicrob Agents 39:545–547CrossRefPubMedGoogle Scholar
  21. 21.
    Potron A, Poirel L, Nordmann P (2014) Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48. Antimicrob Agents Chemother 58:467–471CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Richter SN, Frasson I, Franchin E, Bergo C, Lavezzo E, Barzon L, Cavallaro A, Palù G (2012) KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009–December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units. Gut Pathog 4:7CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Bedenić B, Mazzariol A, Plečko V, Bošnjak Z, Barl P, Vraneš J, Cornaglia G (2012) First report of KPC-producing Klebsiella pneumoniae in Croatia. J Chemother 24:237–239CrossRefPubMedGoogle Scholar
  24. 24.
    Izdebski R, Baraniak A, Fiett J, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Vidal Samso J, Fierro J, Paul M, Lerman Y, Malhotra-Kumar S, Lammens C, Goossens H, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M; MOSAR WP2 and WP5 Study Groups (2013) Clonal structure, extended-spectrum beta-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother 57:309–316CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Ben Sallem R, Ben Slama K, Estepa V, Jouini A, Gharsa H, Klibi N, Sáenz Y, Ruiz-Larrea F, Boudabous A, Torres C (2012) Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 31:1511–1516CrossRefPubMedGoogle Scholar
  26. 26.
    Minandri F, D’Arezzo S, Antunes LC, Pourcel C, Principe L, Petrosillo N, Visca P (2012) Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol 50:590–597CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Liakopoulos A, Miriagou V, Katsifas EA, Karagouni AD, Daikos GL, Tzouvelekis LS, Petinaki E (2012) Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill 17. pii: 20117Google Scholar
  28. 28.
    Saule M, Samuelsen Ø, Dumpis U, Sundsfjord A, Karlsone A, Balode A, Miklasevics E, Karah N (2013) Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia. Antimicrob Agents Chemother 57:1069–1072CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Corvec S, Poirel L, Decousser JW, Allouch PY, Drugeon H, Nordmann P (2006) Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France. Clin Microbiol Infect 12:941–942CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • A. Pantel
    • 1
    • 2
  • A. Boutet-Dubois
    • 2
    • 3
  • H. Jean-Pierre
    • 4
  • H. Marchandin
    • 4
  • A. Sotto
    • 2
    • 5
  • J.-P. Lavigne
    • 1
    • 2
  • on behalf of the CARB-LR group
    • 1
  1. 1.Service de MicrobiologieCHU CarémeauNîmes Cedex 09France
  2. 2.Institut National de la Santé et de la Recherche Médicale, U1047Université Montpellier 1NîmesFrance
  3. 3.Laboratoire de Biologie PolyvalenteCH Alès-CévennesAlèsFrance
  4. 4.Laboratoire de BactériologieCHU Arnaud de VilleneuveMontpellierFrance
  5. 5.Service des Maladies Infectieuses et TropicalesCHU CarémeauNîmesFrance

Personalised recommendations